Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)

NCT04602273 · clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Collaborators